Navigation Links
Study of DuraPrep versus chlorhexidine
Date:10/9/2009

3M Health Care today announced the publication of a new independent study "Effects of Preoperative Skin Preparation on Postoperative Wound Infection Rates: A Prospective Study of 3 Skin Preparation Protocols," that compared the effects of three different skin preparation solutions on surgical-site infections. The study found that Iodophor-based skin preparation solutions, such as 3M DuraPrep Surgical Solution (Iodine Povacrylex [0.7% available Iodine] and Isopropyl Alcohol, 74% w/w) Patient Preoperative Skin Prep, may be superior to chlorhexidine in preventing surgical-site infections.

Authored by Brian R. Swenson, MD, Robert G. Sawyer, MD, and colleagues from the University of Virginia Health System in Charlottesville, VA, the study appears in the October 2009 issue of the journal Infection Control and Hospital Epidemiology.

The study, which examined more than 3,200 general surgery patients during an 18-month period, was performed in concert with ongoing data collection for the American College of Surgeons' National Surgical Quality Improvement Project (NSQIP). This program, which employs a prospective, peer-controlled, validated database to quantify 30-day risk-adjusted surgical outcomes, is a tool to measure and report surgical quality and outcomes and is recognized by the Institutes of Medicine, the Joint Commission and the American Board of Surgery.

"The main findings of the study were somewhat unexpected. Based on data derived from central venous catheter insertions, we had thought that the infection rates would be lowest in the period where chlorhexidine was the preferred agent for skin preparation. This was not the case. If these findings are reproduced in a multicenter study, switching to iodine-based preparations on a broad basis could significantly reduce the huge morbidity and cost associated with surgical site infection in this country and abroad," said Robert G. Sawyer, M.D., Professor of Surgery and Pu
'/>"/>

Contact: Molly Rabinovitz
mrabinovitz@wcpglobal.com
312-646-6294
WeissComm Partners
Source:Eurekalert

2

GOOD

Page: 1 2

Related medicine news :

1. Researchers report benefits of new standard treatment study for rare pediatric brain cancer
2. Feinstein Investigators Receive Federal GO Grant to Study the Genetics of Schizophrenia
3. Miscarriage Treatment Wont Harm Future Fertility: Study
4. Shingles Raises Stroke Risk: Study
5. Major health care challenges persist for D.C. children despite high rates of health insurance coverage, RAND study finds
6. Radiation costs vary widely by delivery, U-M study finds
7. A study to prevent sudden death in sports by means of genetic testing
8. International Study Finds New Best Practices to Reduce Fire Casualties
9. Long-Term Back Pain Not Inevitable, Study Finds
10. Birth Control Pills Might Alter Mate Selection: Study
11. Rare head and neck cancer linked to HPV, study finds

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., , QUINCY, Mass., Nov. 20 Fo...upermarket Company removed from sale Shedd,s Count...i Rice and Shedd,s Country Crock ® Side Dishe...lfite allergen. ,, The following code dates an...® Side Dishes DELUXE Cheddar Broccoli Rice 21...
(Date:11/20/2009)..., , ST. LOUIS, Nov. 20 /PRNewswire-FirstCa...announced that it will present at the Bank of Amer...ld December 2-3, 2009, at the Crowne Plaza Hotel T...resent Wednesday, December 2nd at 8:30 a.m. Easter... access a live, audio webcast of Centene,s present...
(Date:11/20/2009)..., , NEW YORK, Nov. 20 /PRNewswire-FirstC...nnounced that it will broadcast Doctor Radio Re...rams , an in-depth special hosted by veteran journ...om.com/cgi-bin/prnh/20080819/NYTU044LOGO ) ,, ...Know About Mammograms will air November 21 live...
(Date:11/20/2009)...(Seattle, Washington) November 20, 2009Emergency m...s assess an estimated 350,000 cardiac arrests each...dden cardiac arrest survive. Better quality cardi...ital EMS providers may be associated with better p...tium (ROC) is the largest clinical research networ...
(Date:11/20/2009)...nadian study finds more severe cases than with sea...y News) -- Canadian researchers are reporting that...evere cases of H1N1 flu than seasonal flu. , "A...ctor for admission with pandemic H1N1 influenza, p...amples," wrote Dr. Upton Allen and fellow research...
Breaking Medicine News(10 mins):Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
...eveals patients at much greater risk for death , ...ent" heart attacks occur more often than previousl...premature death, according to a Duke University Me...don,t cause any pain and don,t leave behind tellta...
...ces absorption of rapamycin 3 to 4 times , ...t juice boosts the anti-cancer effects of the drug...ed 25 patients with advanced solid tumors, for whi...study, they also drank a glass (eight ounces) of g...
... Corporation (NYSE: SYK ) reported operating res...ws: , , First Quarter Highlights , , , , ...cy basis (2.0% decrease as reported) to $1,601 mil...sed 1.0% on a constant currency basis (5.3% decrea...
...vantages, limits of procedure, study suggests , ...-assisted surgery may be useful for removal of cer..., Their study included 36 patients with oral cavit...e margins (when no cancer cells are found at the e...
...ave a loved one take a look, study says , ... delivers a lifesaving message to older men about ...ma: If you can,t examine your own back, have a lov...it usually is thinner compared to a person finding...
... Medical Innovations, Inc. (NYSE: IMA ), a globa... their health at home through the merger of rapid ... that it will release its first quarter 2009 earni...ts and other corporate matters. During the confere...
Other Medicine News:Health News:'Silent' Heart Attacks More Common Than Thought 2Health News:Grapefruit Juice Boosts Anti-Cancer Drug's Effects 2Health News:Stryker Operating Results for Quarter Ended March 31, 2009 2Health News:Stryker Operating Results for Quarter Ended March 31, 2009 3Health News:Stryker Operating Results for Quarter Ended March 31, 2009 4Health News:Stryker Operating Results for Quarter Ended March 31, 2009 5Health News:Stryker Operating Results for Quarter Ended March 31, 2009 6Health News:Stryker Operating Results for Quarter Ended March 31, 2009 7Health News:Stryker Operating Results for Quarter Ended March 31, 2009 8Health News:Robotic Surgery Practical for Some Head, Neck Tumors 2Health News:Older Men Need to Take Closer Look for Melanomas 2Health News:Older Men Need to Take Closer Look for Melanomas 3Health News:Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 27, 2009 to Discuss First Quarter 2009 Results 2
(Date:11/20/2009)...Nov. 20 Escalon Medical ...for its fiscal first quarter ended September 30, 2... product revenue decreased approximately $234,000,...iod ended September 30, 2009 as compared to the sa...the decreased net revenue of $8,434,000 compared w...
(Date:11/20/2009)...l., Nov. 20 /PRNewswire-FirstCall/ -- Landauer,...r the fiscal fourth quarter and full year of 2009 ... company will host a conference call for investors...n Time. Investors may access the live call by dial...ada), or 480-629-9835 (international callers), or ...
(Date:11/20/2009)...K, Nov. 20 Reportlinker.com announ... in its catalogue. ,, Pipettes & Pipettors....reportlinker.com/p0164373/Pipettes--Pipettors---A...ire&utm_medium=pr&utm_campaign=prnewswire ...ntegral part of any research laboratory. Large-sca...
Breaking Medicine Technology:Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Economic Conditions Signal Long Term Shift in Rx Benefit Approach 57013 1Economic Conditions Signal Long Term Shift in Rx Benefit Approach 57013 2Economic Conditions Signal Long Term Shift in Rx Benefit Approach 57013 3Economic Conditions Signal Long Term Shift in Rx Benefit Approach 57013 4Caliper Life Sciences Launches IVIS 28R 29 In Vivo Imaging System with X Ray 14013 1Caliper Life Sciences Launches IVIS 28R 29 In Vivo Imaging System with X Ray 14013 2Caliper Life Sciences Launches IVIS 28R 29 In Vivo Imaging System with X Ray 14013 3Schering Plough Reports Long Term Vicriviroc Data From Phase II Open Label Extension Study in Treatment Experienced HIV Infected Patients 4990 1Schering Plough Reports Long Term Vicriviroc Data From Phase II Open Label Extension Study in Treatment Experienced HIV Infected Patients 4990 2Schering Plough Reports Long Term Vicriviroc Data From Phase II Open Label Extension Study in Treatment Experienced HIV Infected Patients 4990 3Schering Plough Reports Long Term Vicriviroc Data From Phase II Open Label Extension Study in Treatment Experienced HIV Infected Patients 4990 4Schering Plough Reports Long Term Vicriviroc Data From Phase II Open Label Extension Study in Treatment Experienced HIV Infected Patients 4990 5
...e Phase III ZODIAC study in advanced non-small cel...rug vandetanib, were presented today at the Americ...Orlando. Results show that the study met its prima...ndetanib to docetaxel resulted in a statistically ...al (PFS), the length of time a patient lives witho...
...hat Induction Chemotherapy prior to ChemoRadiother...ure in comparison to standard ChemoRadiotherapy al...ck Cancer Cooperative Group (TTCC) announced today...to standard ChemoRadiotherapy (CRT), a treatment p... upfront CRT alone, significantly prolonged Time-t...
Other Medicine Technology:Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 2Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 3Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 4Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology 5Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer 2Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer 3
...A nonabsorbable knitted product for use in hernior... flexible and compliant material that affords exce...ty, along with maximal porosity for necessary tiss...nstructed from polyethylene terephthalate, the sam...
...The 800 Series KTP/YAG Surgical Laser System is de..., dual-wavelength system designed for urology, gyn...l surgery, neurosurgery, pulmonary surgery and gas...lly cuts, vaporizes and coagulates tissue with min...
...The Gemini is the newest addition to Laserscopes f... distinct wavelengths to choose from, 1064nm Nd:YA...ding non-invasive aesthetic laser market by pushin...ness while maintaining the safety and reliability ...
...The Venus-i Laser System is a new, portable, light...pplications in dermatology, cosmetic and plastic s... ideal laser for skin resurfacing, it is the small...s on the market. It provides an ideal treatment fo...
Medicine Products: